Increased concentrations of MDC/CCL22 in transformed tissues has been shown to lead to T regulatory cells infiltration in melanoma as well as ovarian, prostate, or breast carcinomas [33,34,35]. This evidence concerns the gene CCL22 and breast carcinoma.